[Triamcinolone-assisted vitrectomy in the treatment of recurrent retinal detachment due to myopic macular hole].
OBJECTIVE
To report the use of triamcinolone-assisted vitrectomy to assess the cause of vitrectomy failure in the treatment of retinal detachment due to myopic macular hole.


METHODS
We report the cases of three myopic patients presenting with recurrent retinal detachment due to macular hole after initial vitrectomy treatment with posterior vitreous detachment, a systematic attempt at membrane peeling, and gas injection (SF6). No retinal traction or tear other than the macular hole was observed. The recurrence of retinal detachment was treated with vitrectomy and intraoperative use of triamcinolone, which demonstrated persistent posterior hyaloid and thin and strongly adherent membrane remnants in each case. Anatomic success was obtained after peeling these structures.


CONCLUSIONS
Intraoperative use of triamcinolone reduces the risk of overlooking hyaloid or membrane remnants during vitrectomy for the treatment of myopic retinal detachment. Transparent remnants of posterior hyaloid and membranes were visualized by triamcinolone-assisted vitrectomy. They could lead to traction on the retina and explain the failure of the initial vitrectomy. Anatomic success was obtained after peeling these structures.
Le Rouic
J-F
JF
Département de Chirurgie Vitréo-Rétinienne, Clinique Sourdille, 8, rue Camille, Flammarion, 44000 Nantes.
Ducournau
D
D
Becquet
F
F
D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009216:Myopia / Q000150:complications*; D012008:Recurrence; D012163:Retinal Detachment / Q000209:etiology* / Q000628:therapy*; D012167:Retinal Perforations / Q000150:complications*; D017211:Treatment Failure; D014221:Triamcinolone / Q000627:therapeutic use*; D014821:Vitrectomy
D014221:Triamcinolone